About

Dr Lana McClements

Researcher, innovator, speaker, and women’s health consultant dedicated to advancing healthcare innovation, evidence-based leadership, and meaningful outcomes in women’s health.

Meet Dr Lana McClements

With over 20 years of leadership experience, Lana works at the intersection of women’s health, healthcare innovation, biomedical technology, and commercialisation. Lana help’s organisations navigate emerging trends in FemTech and women’s healthcare through evidence-based consulting, strategic insight, and scientific expertise.

As a speaker, Lana delivers science-backed talks focused on transforming women’s healthcare, advancing leadership, and driving equity, diversity, and cultural change across healthcare, research, and industry sectors.

As a coach, Lana supports women in building confidence, communication skills, leadership capability, resilience, and professional growth. Drawing on my experience leading large multidisciplinary and international teams, I have mentored and coached diverse healthcare professionals, scientists, and biotech leaders.

Associate Professor: University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia
Co-Convenor, INSIGHT Women's and Children's Health Collaborative: University of Technology Sydney, Sydney, Australia
Chair, Science Inclusion, Equity and Diversity Committee: University of Technology Sydney, Faculty of Science, Sydney, Australia
Editor-in-Chief: Taylor and Francis (United Kingdom), Hypertension in Pregnancy, Abingdon, United Kingdom
Senior Lecturer: University of Technology Sydney, Sydney, Australia
Lecturer in Biotechnology: University of Technology Sydney, School of Life Sciences, Sydney, Australia
Honorary Lecturer: Queen's University Belfast, Belfast, United Kingdom
Visiting Scholar: Southern University of Science and Technology, Shenzhen, China

Trusted Voice in Medical Science Media

From national media platforms to academic keynotes, Lana bridges the gap between complex science and public health. Watch her latest insights on translational medicine and maternal health below.

Women’s Health, Healthcare Innovation & Leadership

Lana is a pharmacist, researcher, innovator, and thought leader in women’s health, biomedical technology, and healthcare innovation. Her work sits at the intersection of science, commercialisation, and precision medicine, advancing solutions that improve outcomes for women across pregnancy, cardiovascular disease, cancer, and pathology.

As global investment in women’s health and femtech accelerates, Lana has been at the forefront of translating scientific discovery into real-world healthcare innovation. Her research led to the discovery of novel blood-based biomarkers for preeclampsia, a life-threatening pregnancy complication, which were translated into in vitro diagnostic (IVD) technologies for both laboratory and point-of-care testing using lateral flow assays.

Recognised internationally for her expertise in women’s health and sex differences in medicine, Lana was invited to lead an international seminar publication for Sex Differences in Health Awareness Day, contributing to greater awareness of how biological sex influences disease, diagnosis, and treatment outcomes.

Addressing the critical need for improved pregnancy research models, Lana and her team also pioneered the development of 3D bioprinted first-trimester placental organoids, or “mini-placentas”, through collaboration with a Sydney-based biotech start-up. This innovative platform enables high-throughput development of biomarkers and therapies for placental dysfunction and pregnancy-related disease.

Her broader work includes contributing to patient-derived “mini-heart” technologies for the early detection of cardiovascular disease in women at risk, as well as designing and translating therapies targeting diseases affecting women, from cancer to cardiovascular and pregnancy-related conditions.

More recently, Lana has led the commercialisation of a quantum-based imaging platform for pathology, further expanding her impact across emerging healthcare technologies.

With experience spanning discovery science, translational medicine, biotechnology, diagnostics, and commercial innovation, Lana brings a rare breadth of expertise across the full healthcare ecosystem, from molecule to patient.